Trasis is a leading brand dedicated to advancing nuclear medicine and radiopharmaceuticals technology, ultimately aiming to improve health and wellbeing. With an unwavering commitment to innovation, Trasis has become a trusted name in the industry. With a diverse team of over 50 skilled professionals, Trasis has established itself as a powerhouse in the field.

The company currently operates three subsidiaries, showcasing its ability to drive growth and expansion. Over the past 20 years, Trasis has achieved significant milestones in the industry. From the design of the first radio-synthesizer to the development of groundbreaking products like the Unidose and Quickfill dispensers, Trasis has consistently pushed the boundaries of what is possible.

Trasis synthesizers, including the AllinOne and miniAllinOne, enable the development and production of radiotracers for routine use and research purposes. Additionally, Trasis offers regulatory support services and operates a state-of-the-art Clean Room facility for synthesizer consumable production. With a growing team of 230 employees and a dedication to continuous growth, Trasis is shaping the future of nuclear medicine technology.

Experience the difference in radiopharmaceutical innovation with Trasis